Monopar Therapeutics Inc. · NASDAQ:MNPR
Janus Henderson Group PLC reported a 19.50% stake in Monopar Therapeutics Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Janus Henderson Group PLC reported a 19.50% stake in Monopar Therapeutics Inc., 1,287,368 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 19.50%
- Shares
- 1,287,368
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 19.50% | 1,287,368 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 16.70% | 1,105,471 |
Source
Related
- Monopar Therapeutics Inc.
- Janus Henderson Group PLC
- Monopar Therapeutics Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Jan 8, 2025
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026